Literature DB >> 12923346

Recurrent mesectodermal leiomyoma of the ciliary body: a case report.

Seong Hwan Park1, Ji-Hye Lee, Yang Seok Chae, Chul Hwan Kim.   

Abstract

A 19-yr-old woman with a previous history of a mass of the right ciliary body presented with a decreased visual acuity of right eye. Clinicoradiologic examinations suggested a recurrent mass of the ciliary body. Enucleation of the right eye was performed under the impression of malignant tumor. On microscopic examination, the tumor was a mesectodermal leiomyoma of the ciliary body. On immunohistochemistry, the tumor cells were reactive to smooth muscle actin and vimentin, but not reactive to cytokeratin, S-100 protein, neurofilament, desmin, epithelial membrane antigen, HMB-45, glial fibrillary acidic protein, and synaptophysin. Electron microscopy revealed numerous thin longitudinally placed myofilaments and focal densities in the cytoplasms. In the review of the literature, only 27 cases of mesectodermal leiomyoma of the ciliary body were reported, however, there was no report of recurrent cases. Mesectodermal leiomyoma should be differentiated from other orbital spindle-cell tumors such as amelanotic melanomas and glial tumors. Immunohistochemical and electron microscopic studies may be useful for the correct diagnosis by showing smooth muscle differentiation in the tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923346      PMCID: PMC3055091          DOI: 10.3346/jkms.2003.18.4.614

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  2 in total

1.  A case of ciliary body mesectodermal leiomyoma with rapid growth and loss of vision necessitating enucleation.

Authors:  Hind M Alkatan; Saad A Al-Dahmash; Hamad Aljaedi
Journal:  Ann Med Surg (Lond)       Date:  2020-11-27

2.  Acute Presentation of Mesectodermal Leiomyoma of the Ciliary Body.

Authors:  Jenna May Kim; Laura Bressler Hall; Maxwell Elia; Michael S Ehrlich; Miguel A Materin; John H Sinard
Journal:  Ocul Oncol Pathol       Date:  2017-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.